Related Experiment Video
Updated: Jun 19, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Clopidogrel application: beyond coronary artery disease.
1Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, People’s Republic of China; Department of Cardiology, The First Affiliated Hospital, Shantou Medical College, Shantou University, Shantou City,People's Republic of China.
Clinical Science (London, England : 1979)
|November 6, 2009
Summary
Clopidogrel, an antiplatelet medication, normalized vascular dysfunction in rat mesenteric arteries. Further research is needed to confirm its benefits in patients with hypertension or diabetes.
Area of Science:
- Cardiovascular Pharmacology
- Vascular Biology
Background:
- Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel is standard for cardiovascular conditions.
- Clopidogrel is a P2Y12 antagonist crucial in managing stroke, peripheral arterial disease, and acute coronary artery disease.
Purpose of the Study:
- To investigate the effects of clopidogrel on vascular function in a rat model of hypertension.
- To explore potential new applications for clopidogrel beyond its established antiplatelet role.
Main Methods:
- Utilized angiotensin II-infused Sprague-Dawley rats to induce vascular dysfunction.
- Assessed vascular responses to phenylephrine (contraction) and acetylcholine (vasodilation) in mesenteric arteries.
Main Results:
- Clopidogrel treatment normalized heightened phenylephrine-induced vascular contraction.
- Clopidogrel restored impaired acetylcholine-induced vasodilation in the mesenteric arteries.
Conclusions:
- Clopidogrel demonstrated a potential to ameliorate vascular dysfunction in a preclinical model.
- Further investigation is warranted to determine clopidogrel's efficacy in hypertensive or diabetic patients and its comparative benefit against aspirin.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...